STADA Arzneimittel AG
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
SAZ | HM
Overview
Corporate Details
- ISIN(s):
- DE0007251803 (+1 more)
- LEI:
- 529900FMTTLMH0P0DL10
- Country:
- Germany
- Address:
- Stadastraße 2 - 18, 61118 Bad Vilbel
- Website:
- https://www.stada.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
STADA Arzneimittel AG is a global pharmaceutical company operating with a three-pillar strategy consisting of Generics, Consumer Healthcare, and Specialty Pharmaceuticals. The company is a leading European player in its core segments, ranking as the fourth-largest manufacturer of both generics and consumer healthcare products. Its Generics division focuses on providing affordable medicines. The Consumer Healthcare business is driven by a portfolio of strong regional and 'Local Hero' brands. The Specialty Pharmaceuticals segment develops and markets innovative treatments for specific conditions, including biologic therapies. With a heritage rooted in pharmacies and dating back to 1895, STADA's purpose is to be a trusted partner in caring for people's health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-20 00:00 |
Post-Annual General Meeting Information
Datum:20.08.2025
|
German | 9.6 KB | ||
| 2025-08-11 00:00 |
Annual Report
Datum:11.08.2025
|
German | 2.2 MB | ||
| 2025-07-07 00:00 |
Post-Annual General Meeting Information
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 5.6 KB | ||
| 2025-02-04 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 564.0 KB | ||
| 2025-01-21 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 1.8 MB | ||
| 2024-02-14 00:00 |
Annual Report
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 536.7 KB | ||
| 2024-01-10 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 1.5 MB | ||
| 2023-02-23 14:15 |
Report Publication Announcement
|
English | 3.9 KB | ||
| 2023-02-23 11:25 |
Report Publication Announcement
|
English | 4.0 KB | ||
| 2023-02-23 00:00 |
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
|
German | 5.7 KB | ||
| 2023-02-23 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
|
German | 5.7 KB | ||
| 2022-09-27 00:00 |
Annual / Quarterly Financial Statement
Ergänzung der Veröffentlichung vom 12.04.2022
|
German | 2.2 KB | ||
| 2022-08-17 09:49 |
Report Publication Announcement
|
English | 4.0 KB | ||
| 2022-08-17 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
|
German | 5.7 KB | ||
| 2022-05-10 00:00 |
Regulatory News Service
Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 911.5 KB |
Automate Your Workflow. Get a real-time feed of all STADA Arzneimittel AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STADA Arzneimittel AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STADA Arzneimittel AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}